Medicine

The centre aims to discover new drug targets for diseases such as Parkinson’s and hypertension The UK Research and Innovation’s (UKRI) Medical Research Council

ABPI has appointed Russell Abberley as Acting President The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Acting President. Abberley,

The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex The World Health Organization (WHO) has announced that it has added Bavarian

Innovative immunotherapy drug HTL0039732 shows potential in trials Nxera Pharma and Cancer Research UK are set to present their ongoing Phase 1/2a clinical trial

GlobalData emphasises importance of Improved clinical trials World Sepsis Day, observed annually on 13 September, aims to raise awareness about sepsis, a life-threatening condition

Chemistry is the cornerstone of modern civilisation, playing a crucial role in virtually every aspect of our lives. From the food we eat and

Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its partner, Centessa Pharmaceuticals, has

New study highlights potential benefits of menopausal hormone therapy A recent study published in the American Journal of Psychiatry suggests that menopausal hormone therapy

New evidence highlights AI’s potential in early lung cancer detection At the IASLC 2024 World Conference on Lung Cancer in San Diego, a new

Patients with relapsed multiple myeloma gain access to life-extending therapy The Scottish Medicines Consortium (SMC) has approved Tecvayli – also known as teclistamab –

Critically ill individuals will benefit from futuristic tech APL, one of Sweden’s largest manufacturers of extemporaneous medicines and a leading contract development and manufacturing

Molecular imaging agent 99mTc-maraciclatide to aid in disease prognostication Serac Healthcare, a clinical radiopharmaceutical company, and the University of Exeter have announced the commencement

Research suggests that LLMs could be used to support trainee doctors, nurses and GPs The chatbot ChatGPT performed better than trainee doctors in assessing

Enhancing HCP engagement – on-demand strategies from Veeva Speed and relevance are crucial in interactions between biopharma companies and healthcare professionals (HCPs). Data from

New treatment could simplify diabetes management for millions Eli Lilly and Company has announced promising results from two phase 3 clinical trials, QWINT-1 and

Leonie Goddard is Practice Manager, Strategic Insights at Veeva Systems Ethos Veeva is the global leader in cloud software for the life sciences industry.

Pre-clinical data of VTX-806 in demonstrated normalisation of metabolic parameters Vivet Therapeutics, a clinical-stage biotech company developing novel gene therapies for rare liver metabolic

New biomarker test aims to improve early-stage melanoma treatment AMLo Biosciences has announced the successful receipt of the UKCA mark for AMBLor, a groundbreaking

Mogrify has appointed Dr Jonathan Appleby as Chief Scientific Officer Mogrify has announced the appointment of Dr Jonathan Appleby as Chief Scientific Officer. With decades of industry

Curve has appointed Simon Jones as Chief Operating Officer Curve Therapeutics has announced the appointment of Simon Jones as Chief Financial Officer and Chief Operating Officer. Simon

Cellular Origins has appointed Geoffrey Hodge to its board Cellular Origins has announced the appointment of Geoffrey Hodge to its board as Non-Executive Director. Leveraging extensive expertise,

VectorY has appointed Adam Rosenberg as the new Chair of the Board. VectorY Therapeutics has announced the appointment of Adam Rosenberg as the new Chair of the

AbbVie has appointed Steve Hopkinson as UK Vice President AbbVie has appointed Steve Hopkinson as Vice President and General Manager, UK. Steve will succeed Todd Manning, who retires from AbbVie

Optibrium has appointed James Halle as Chief Commercial Officer Optibrium has announced the appointment of James Halle as Chief Commercial Officer. James brings extensive software experience in

A bold new opportunity to address research challenges So, now we have a new Government, there is a new opportunity to address the challenges

The partnership will improve care for patients with pancreatic cancer myTomorrows, a global health technology company connecting patients with all possible treatment options, has

However the company will not continue developing the candidate Acelyrin has shared positive results from a late-stage study of its IL-17A inhibitor izokibep in

The spread of multiple bacteria could be tracked simultaneously through sequencing method Using a genomic approach, researchers have developed a way to simultaneously track

Over 135,000 people have signed a petition to prioritise a national screening programme The charity Prostate Cancer Research (PCR) has launched a national campaign,

The conference will be held in Basel, Switzerland from 26-28 August Press release: The Association for Medical Education in Europe AMEE 2024 conference will

Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms The Medicines and Healthcare products Regulatory Agency (MHRA) has

The grant will support clinical trials of rare disease therapy for leukodystrophy Oxford-based SynaptixBio has been awarded a £2m BioMedical Catalyst grant from Innovate

200,000 people in the UK have what is considered a ‘hidden’ lung condition Bronchiectasis is the third most common lung condition in the UK

Globally 400,000 children are impacted every year by cancers that include leukaemia and lymphoma UK’s Great Ormond Street Hospital (GOSH) Children’s Charity and the

The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods Press release: QuantaMatrix,

The company’s Cell & Gene Therapy Centre can now offer a full range of GMP services Press release: eXmoor pharma, the full-service cell and

Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause Theramex’s Eladynos (abaloparatide) has been recommended by the National

In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project Colorectal cancer (CRC) is the third most commonly diagnosed cancer

The contract concerns profiling Immunoglobulin E autoantibodies in blood serum Oncimmune, an autoantibody profiling company providing research services to the pharmaceutical and biotechnology industry

This form of cancer was responsible for 1.9 million diagnosed cases worldwide in 2020 A study led by researchers at the University of Leeds

The study yielded over one million dose-responsive curves for existing cancer drugs Researchers from the Technical University of Munich (TUM) have successfully mapped the

Children accounted for the majority of mpox cases and deaths in the DRC since June 2023 Researchers from McMaster University have received $6.7m from

Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK Researchers from Newcastle University, Great North Children’s Hospital, Cambridge University Hospital

The findings could improve cancer treatment and drug delivery to treat tumours Researchers from King’s College London’s (KCL) School of Biomedical Engineering and Imaging

Heart failure with preserved ejection fraction makes up 50% of all UK heart failure cases A study led by King’s College London (KCL) has

The rare, peripheral neuropathy disease affects nearly three million people globally The CMT Research Foundation (CMTRF) has invested in a research project based at

The V-ATPase protein, V1H, was found to be involved in the process of raising the alarm Scientists at the Francis Crick Institute have revealed

A second dose of the vaccine lowered the incidence of conditions such as heart attack or stroke Researchers from the Universities of Cambridge, Bristol

Bowel cancer was the most common cancer to be identified in both men and women Researchers from University College London (UCL) have found that

In the UK, there are an estimated 11 million people living with a neurological condition Researchers from King’s College London have developed a new

The study revealed that 13% of patients have a genetic form of the neurological disease A US study supported by the Parkinson’s Foundation has

EU AI Act – challenges and opportunities for pharmaceuticals

Lung cancer accounts for an estimated two million global diagnoses and 1.8 million deaths Researchers from the University of Leeds have developed a new

The study predicted the development of conditions including Alzheimer’s and heart disease Researchers from the University of Edinburgh, along with commercial collaborators Optima Partners

Type 1 diabetes accounts for approximately 10% of diabetes cases in the UK A new study led by researchers from Cardiff University, King’s College

Researchers aim to explore and investigate axonal dysfunction in neurodegeneration The Medical Research Council and the Motor Neurone Disease (MND) Association have awarded researchers

Cardiovascular diseases currently affect around seven million people in the UK, including coronary heart disease The British Heart Foundation (BHF) has awarded five research

Neurological conditions, including Alzheimer’s disease, are the leading cause of ill health globally Researchers from the University of Glasgow, in collaboration with Tel Aviv

Bowel cancer, the third most common cancer type worldwide, is the second most common cause of cancer death Researchers from ETH Zurich, Switzerland, have

Head and neck cancer is currently recognised as the sixth most common cancer globally Researchers from Guy’s and St Thomas’ and King’s College London

Cancer is estimated to affect more than three million people living in the UK, according to Macmillan Cancer Support Researchers from the Dana-Farber Cancer

The third leading cause of cancer mortality accounts for over 700,000 deaths every year A study conducted by researchers from the National Cancer Institute

Combined, ovarian and breast cancer affect over 60,000 women in the UK every year Researchers from Manchester University NHS Foundation Trust (MFT) have revealed

The collaboration aims to develop new medicines to reduce chronic kidney disease in Scotland NHS Scotland, AstraZeneca (AZ) and the Universities of Glasgow and

The latest collaboration marks Apollo’s sixth agreement with a research institution Apollo Therapeutics and the University of Oxford have entered into a drug discovery

Quantum-based technologies will explore infectious diseases, cancer and dementia The Engineering and Physical Sciences Research Council (EPSRC) has announced the launch of two new

The rapidly progressive neurological condition affects around 5,000 people in the UK Health Data Research UK (HDR UK) and Dementias Platforms UK (DPUK) have

The findings could support investigations into human genetics and various complex diseases Researchers from the Wellcome Sanger Institute, the University of Cambridge and AstraZeneca

The neurodegenerative condition is recognised as the most common form of dementia A study conducted by researchers at the Massachusetts Institute of Technology (MIT)

Coronary heart disease is the most common form of heart and circulatory disease Researchers from the University of Edinburgh, in collaboration with Heriot-Watt University,

The neurological disease is estimated to affect more than ten million people globally The Michael J. Fox Foundation (MJFF) has awarded $6m to Lario

Researchers predicted the onset of 67 diseases, out-performing current standard models A study conducted in partnership between University College London (UCL), GSK, Queen Mary

The new Human Gut Microbiome Atlas could help treat conditions including IBS and AMR Researchers from King’s College London (KCL) have developed a new

Conditions such as Alzheimer’s and Parkinson’s affect over one million people in the UK Researchers from King’s College London (KCL), along with other collaborators,

The research will help to better understand how this pathway is coordinated in the cell The Medical Research Council (MRC) has awarded £1.2m to

Affecting over 250,000 people, bowel cancer is the fourth most common cancer in the UK Researchers from Imperial College London have revealed that a

The neurodegenerative disease is currently the most common cause of dementia A study led by the UK Dementia Research Institute (UK DRI) and University

The life-threatening medical condition affects 100,000 people in the UK every year Researchers from Boston University School of Public Health (BUSPH) and the University

The truth hurts. B2B healthcare advertising frequently misses the mark. As someone who leads a healthcare division at a creative agency, that’s hard for

Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK A new study published in Nature Medicine, led by

Primary sclerosing cholangitis is estimated to affect one in 100,000 people worldwide annually A new clinical trial led by the University of Birmingham aims

The progressive neurodegenerative condition affects around 153,000 people in the UK Researchers from the Universities of Nottingham and Birmingham have revealed that a new

Accreditation recognises ‘continued professional development’ opportunities As part of the Healthcare Communications Association’s partnership with this year’s PharmaTimes Communications Awards, we can now confirm

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia Scientists from the University of Glasgow have developed the first bioengineered bone

Chronic pelvic pain is a disabling condition that affects around one in four women worldwide A study led by the University of Edinburgh in

Genentech’s Pulmozyme could also treat other respiratory infections and conditions Researchers from University College London (UCL), UCL Hospital (UCLH) and the Francis Crick Institute

The most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths A study led by researchers from the Institute

The most globally prevalent cancers include breast, lung, bowel and prostate cancers Researchers from Johns Hopkins Kimmel Cancer Center and its Ludwig Center, along

The new technology can generate a target infection within 30 minutes to two hours Researchers from McMaster University, with support from experts at Université

Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK King’s College London (KCL) has led

Exonate has appointed Dr Rafiq Hasan as Non-Executive Director. Exonate has announced the expansion of its Board with the appointment of Dr Rafiq Hasan as Non-Executive Director. Rafiq brings

Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress The National Institute for Health and Care Research (NIHR)

Affecting parts of the body involving breathing, RTIs impact one in five people in England A new trial led by researchers from the University

The serious, rare condition is responsible for up to 7% of all neonatal deaths globally Researchers from the University of Birmingham are developing a

The progressive neurodegenerative disease affects more than 55 million people globally Innovate UK has awarded £4m through its Contracts for Innovation to four UK

The awards celebrated both medical affairs and nursing professionals in the industry The PharmaTimes Medical & Scientific Awards (MSEA) and the Nursing Industry Excellence

Macmillan Cancer Support estimates that cancer affects over three million people in the UK A new policy review produced by cancer doctors and experts

The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care Dementia researchers from the University of Liverpool have been awarded £1.5m

The neurodegenerative condition currently affects more than 944,000 people in the UK University College London (UCL) and the University of Exeter are set to

Around one in five dementia hospitalisations are due to potentially preventable causes The UK Dementia Research Institute (UK DRI), in collaboration with the NHS,

The serious, progressive kidney disease affects nearly 850 million people worldwide The Scottish Medicines Consortium (SMC) has accepted Boehringer Ingelheim and Eli Lilly’s Jardiance

Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer The Francis Crick Institute and Imperial College London (ICL) cancer therapy spinout, Myricx

The progressive neurodegenerative condition affects around 153,000 people in the UK Mission Therapeutics has been awarded $5.2m in funding from Parkinson’s UK’s Virtual Biotech

More than 176,000 people in the UK are living with a stoma, according to NHS data Coloplast has announced the launch of its world-first

Frontier Science Scotland appoints Prof Bjoern Schelter as a Director to its Board of Trustees Frontier Science Scotland has announced the appointment of Professor Bjoern Schelter as a new

Kronos Bio has appointed Deborah Knobelman as Chief Operating Officer Kronos Bio has appointed Deborah Knobelman as Chief Operating Officer and Chief Financial Officer. She will oversee the finance, accounting,

The neurodegenerative disease currently affects more than 200,000 people worldwide NeuroSense Therapeutics has announced positive mid-stage results of its lead drug candidate, PrimeC, in

Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide A study, published in Nature, has revealed a new way to map the

The progressive neurological condition affects around 153,000 people in the UK Herantis Pharma has been awarded €3.6m in funding from Parkinson’s UK’s Virtual Biotech

Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses Scientists from the Institute of Cancer Research (ICR) have revealed new

Chronic migraine is a neurological condition estimated to affect up to 2.2% of people globally A study led by researchers at King’s College London

Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK

As research advances, allowing scientists to more clearly pinpoint the underlying causes of disease, new drugs are becoming more precise and highly targeted. At

Affecting around 3,755 young people in the UK every year, leukaemia is the most commonly diagnosed cancer in children Researchers from the Wellcome Sanger

Weight loss drugs are the word on the street and it’s getting serious With all the noise surrounding ‘miracle’ weight loss drugs recently, it

The biotech company will develop novel therapeutic drugs for the treatment of fatal diseases The University of Liverpool has announced the launch of a

The neurodegenerative condition currently affects around 153,000 people in the UK Parkinson’s UK has awarded nearly £100,000 to researchers at Imperial College London (ICL)

The study found an increase in incidence among young people and people from deprived areas A study conducted by European researchers from the University

Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy A new study sponsored by University College London (UCL) has begun, making

Langerhans cell histiocytosis currently affects around one in 200,000 children in the UK A new collaboration between Newcastle University, the Wellcome Sanger Institute (Sanger)

AD is the most common form of dementia, which affects over 944,000 people in the UK Researchers from the University of Sheffield’s Institute of

The initiative’s proposals aim to tackle current challenges in health research and innovation The Innovative Health Initiative (IHI) has launched a new call for

An estimated 27% of patients globally living with diabetes will be affected by retinopathy A study conducted by Oxford Population Health has demonstrated that

Atherosclerotic plaques in the arteries affect 42% of adults living without heart disease Researchers from the University of Bristol have revealed a new disease-driving

The initiative aims to improve African pandemics, outbreaks, preparedness and responses The EU, its Member States and European financial institutions have announced a more

The manifesto calls on the next UK government to make dementia a key health priority Alzheimer’s Society, Dementia UK, Alzheimer’s Research UK, the UK

Medulloblastoma is responsible for around 52 new cases in children in the UK every year A new study led by Newcastle University and the

Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020 Leuko, founded by researchers at the Massachusetts Institute of

According to WHO, cardiovascular diseases are responsible for 17.9 million annual deaths Researchers from Innsbruck Medical University, Austria, have developed a new treatment that

The method provides a more accurate and ethical approach to drug testing for medicines Researchers from King’s College London (KCL) have created a mini

The lifelong inflammatory bowel disease affects around one in every 350 people in the UK Researchers from the University of Cambridge have grown ‘mini-guts’

The progressive neurodegenerative condition affects more than ten million people worldwide Researchers from Johns Hopkins Medicine have revealed that a cancer drug could be

The serious condition is responsible for approximately 11 million deaths worldwide every year Researchers from the Wellcome Sanger Institute, the University of Oxford and

Congenital melanocytic naevus syndrome can cover up to 80% of the bodies of children Researchers from the Francis Crick Institute, University College London (UCL)

Stroke causes over seven million new cases annually, ranking second in leading global mortality Researchers from King’s College London (KCL) and the University of

The progressive neurological disorder currently affects more than 200,000 people worldwide The University Medical Center (UMC) Utrecht, Netherlands, has announced that it has enrolled

The mosquito-borne viral disease is responsible for an estimated 390 million cases globally LifeArc has announced that it will be funding three new projects

The installation will double the capacity of cancer genomic testing using robotic automation The Royal Marsden NHS Foundation Trust has launched the UK’s first

NSCLC accounts for around 85% of all lung cancer cases, particularly in non-smoking patients Researchers at the Francis Crick Institute, University College London (UCL)

AMR is designated as one of the top ten global public health threats facing humanity by WHO Sysmex Astrego AB, a subsidiary of Sysmex

Technology is key to recruiting and retaining clinical trial participants

The donation will help scientists and clinicians collaborate and make new advances in research Imperial College London (ICL) has received a £10m donation from

Two support cells, microglia and astrocytes, were found to communicate with each other Researchers at the Francis Crick Institute, University College London’s UK Dementia

Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally Lucy Therapeutics (LucyTx) has announced it has raised $12.5m in additional

The leading cause of cancer globally accounts for an estimated 1.8 million deaths annually Researchers from the Johns Hopkins Kimmel Cancer Center and other

Accounting for 4% of all cases, kidney cancer is currently the sixth most common cancer diagnosed in the UK The Dana-Farber Cancer Institute and

Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK Researchers from University College London (UCL) and Great Ormond

What can pharma do to proactively take on climate change?

Phase 2 trial reveals significant improvement in MASH patients Boehringer Ingelheim has unveiled promising results from a Phase II trial of survodutide, demonstrating a

Early-stage endometriosis now visible through non-invasive imaging In a significant advancement for endometriosis diagnosis, Serac Healthcare, in collaboration with the University of Oxford, has

Innovative antibody discovery could lead to new Parkinson’s treatments Cambridge-based Alchemab Therapeutics has been awarded a substantial grant from The Michael J. Fox Foundation

Inebilizumab shows sound efficacy in landmark research Amgen has announced a breakthrough in the treatment of Immunoglobulin G4-related disease (IgG4-RD) with its phase 3

Extended phase 2 study highlights macrophage cell therapy’s efficacy Resolution Therapeutics Limited, in collaboration with the University of Edinburgh, has presented compelling clinical data

Phase 3 research suggests a significant leap forward in myeloma management Sanofi’s Sarclisa, a novel treatment for multiple myeloma, has demonstrated a substantial improvement

Positive clinical data from phase 1 study presented at ASCO annual meeting invoX Pharma Limited has presented updated findings from its phase 1 study

Collaboration yields promising Barriolide therapy Enterothelin EpiEndo Pharmaceuticals, a clinical-stage biopharmaceutical company, and AlveoliX, an innovator in organ-on-chip technology, have announced significant advancements in

The platform will be used to diagnose and treat cancers, including lung and brain tumours A new international study led by King’s College London

Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy A new type of immunotherapy developed by researchers

The CVLP platform will speed up access to BioNTech and Genentech’s mRNA personalised cancer vaccines The NHS has announced that it has treated its

The projects will focus on a range of research areas, including Down’s syndrome and ALS The Francis Crick Institute has announced six new partnerships

Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns A new study led by Newcastle

The first phase of the programme will be in place in hospitals across the UK by March 2025 The NHS has announced the roll

The proposals will help MedTech developers access NHS funding to fast-track products NHS England and the National Institute for Health and Care Excellence (NICE)

Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or circulation The British Heart Foundation (BHF)

The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until March 2029 The Medical Research Council

The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1 LifeArc and the ALS Therapy Development Institute (ALS TDI) have partnered

JHU083 reduced tumour growth and triggered tumour cell death in mice Researchers from the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Drug Discovery

The lifelong autoimmune disease affects more than 150,000 people living in the UK A new King’s Doctoral Training Centre at the Institute of Psychiatry,

Why a global approach can accelerate innovation Rare diseases are a global public health priority: approximately 400 million people are affected across the globe1

Navigating regulatory and safety hurdles in global clinical trials In the dynamic global drug development industry, achieving success requires more than just innovative therapies

Patient-centricity, involvement or engagement? Greater patient-centricity in the medicines research and development process can benefit everyone, from patients to industry to policymakers. There are

A shift in collaborative academia-industry clinical trials The collective landscape of academia-industry clinical trials is undergoing a period of transformation in response to last

BOBI Awards 2024 – celebrating excellence in healthcare business insights The BHBIA has recognised the achievements of the UK’s healthcare business insights industry at

The partnership will provide six MRC clinical fellows with industry placement opportunities The Medical Research Council (MRC) and pharmaceutical company AstraZeneca (AZ) have partnered

High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours Researchers in the US and UK are

The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines A new technology developed by researchers from King’s College

Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually Researchers from the University of Liverpool and Queen Mary

The network will support the development, evaluation and adoption of innovative health and care technology The National Institute for Health and Care Research (NIHR)

The funding aims to reduce health inequalities in these groups and save more lives The Community Grants Programme led by NHS Blood and Transplant

Both drugs have the potential to offer a disease-modifying approach to the lung disease Vicore Pharma and Endeavor BioMedicines have shared new data from

Globally affecting 4% of the population, autoimmune diseases mistakenly attack healthy cells, tissues and organs in the body Researchers from King’s College London’s (KCL)

Spread through Anopheles mosquitoes, the disease affected around 249 million people globally in 2022 Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG)

Areas include health research across life stages, from paediatrics to health ageing and resilience The University of Liverpool and McMaster University have announced an

The OptiZest study aims to investigate a personalised dose of Zestril in these patients Closed Loop Medicine and Pharmanovia have announced the initiation of

The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK Researchers from Imperial College London (ICL), the Alan Turing Institute and

The condition is the ninth most common cancer in the UK and affects 12,300 people annually The National Institute for Health and Care Research

The autoimmune disease, which affects 1.5 million people in the US, causes the body’s immune system to attack its own tissues Researchers from Johns

Heart failure is a cardiovascular disease that affects more than 64 million people worldwide A study led by researchers from the University of Glasgow

More than 3,000 people in England were affected by Strep A between September 2022 and May 2023 A new analysis led by the UK

Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 July 2024 PharmaTimes is

Bioluminescence used MRI to observe the dilation of luciferase in engineered blood vessels Engineers from the Massachusetts Institute of Technology (MIT) have developed a

The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance The Medicines and Healthcare products Regulatory Agency (MHRA) has

For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer The NHS has announced, for the

The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells OneChain Immunotherapeutics (OCI),

Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024 Oregon Therapeutics and Lantern Pharma have entered into

Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications Chiesi Group and Gossamer Bio have announced a global collaboration and license

The findings could potentially lead to new therapies and could stop the growth of cancers Johns Hopkins Medicine scientists have revealed a molecular pathway

The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK The Francis Crick Institute and Broken String Biosciences

The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK  The NHS has announced that it will be